We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pursuing De Novo Clearance: A Pathway for Xenex Germ-Zapping Robots
Pursuing De Novo Clearance: A Pathway for Xenex Germ-Zapping Robots
The FDA’s de novo program is the best pathway to market authorization for devicemakers developing a unique product that has “no substantial equivalent” (NSE) device already cleared by the agency.